Automated Guidelines for Healthcare Reimbursement Series – Part 2: Preauthorization for Targeted Drug Therapy and Streamlining of the Appeals
Blog: Trisotech
Automated Guidelines for Healthcare Reimbursement Series Part 2: Preauthorization for Targeted Drug Therapy and Streamlining of the Appeals As presented by: Denis Gagné, CEO and John Svirbely, CMIO of Trisotech Targeted drug therapy can be very expensive, and insurance companies do not want to pay for it when it is not indicated. In the second […]
The post Automated Guidelines for Healthcare Reimbursement Series – Part 2: Preauthorization for Targeted Drug Therapy and Streamlining of the Appeals appeared first on Trisotech.
Leave a Comment
You must be logged in to post a comment.